Direct-to-Consumer DNA Privacy Risks
Coverage from Newsanyway, The New York Times Wirecutter, and others

Direct-to-consumer DNA testing companies collect highly sensitive genetic information under privacy policies that may provide the primary consumer safeguards, because many firms are not HIPAA-covered entities.
The material highlights exposure from breaches, law-enforcement access, corporate acquisitions, research and AI commercialization, and the limits of de-identification. U.S. state laws are expanding consent and disclosure requirements, but protections and legal interpretations remain fragmented.
The story broadens from privacy and bankruptcy concerns into a wider account of how consumer genetic data can be accessed, retained, and commercialized across breaches, acquisitions, law-enforcement requests, and AI partnerships. It also now places more emphasis on state-level legal fragmentation and voluntary industry standards rather than just consumer-protection gaps.
